Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Milan
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776259/ |
| id |
pubmed-3776259 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-37762592013-09-20 Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response Sánchez-Rovira, P. Seguí, M. A. Llombart, A. Aranda, E. Antón, A. Sánchez, A. Lomas, M. Jaén, A. Fernández, M. Porras, I. Dalmau, E. Morales, S. de la Haba-Rodríguez, J. Research Article Springer Milan 2013-02-09 2013 /pmc/articles/PMC3776259/ /pubmed/23397155 http://dx.doi.org/10.1007/s12094-013-1006-4 Text en © The Author(s) 2013 |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Sánchez-Rovira, P. Seguí, M. A. Llombart, A. Aranda, E. Antón, A. Sánchez, A. Lomas, M. Jaén, A. Fernández, M. Porras, I. Dalmau, E. Morales, S. de la Haba-Rodríguez, J. |
| spellingShingle |
Sánchez-Rovira, P. Seguí, M. A. Llombart, A. Aranda, E. Antón, A. Sánchez, A. Lomas, M. Jaén, A. Fernández, M. Porras, I. Dalmau, E. Morales, S. de la Haba-Rodríguez, J. Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| author_facet |
Sánchez-Rovira, P. Seguí, M. A. Llombart, A. Aranda, E. Antón, A. Sánchez, A. Lomas, M. Jaén, A. Fernández, M. Porras, I. Dalmau, E. Morales, S. de la Haba-Rodríguez, J. |
| author_sort |
Sánchez-Rovira, P. |
| title |
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| title_short |
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| title_full |
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| title_fullStr |
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| title_full_unstemmed |
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response |
| title_sort |
bevacizumab plus preoperative chemotherapy in operable her2 negative breast cancer: biomarkers and pathologic response |
| description |
|
| publisher |
Springer Milan |
| publishDate |
2013 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776259/ |
| _version_ |
1612012385181106176 |